{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:14:55Z","timestamp":1793420095940,"version":"4.5.0"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jconrel.2023.02.040","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T11:07:55Z","timestamp":1679396875000},"page":"623-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"special_numbering":"C","title":["Reactive oxygen species-powered cancer immunotherapy: Current status and challenges"],"prefix":"10.1016","volume":"356","author":[{"given":"Mengying","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.02.040_bb0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative stress in cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0015","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1021\/acsnano.8b01893","article-title":"All-in-one theranostic nanoagent with enhanced reactive oxygen species generation and modulating tumor microenvironment ability for effective tumor eradication","volume":"12","author":"Liu","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0020","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/anie.201805664","article-title":"Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions","volume":"58","author":"Tang","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103285","article-title":"Reactive oxygen species (ROS): critical roles in breast tumor microenvironment","volume":"160","author":"Malla","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0030","doi-asserted-by":"crossref","first-page":"1906805","DOI":"10.1002\/adfm.201906805","article-title":"Phase-change materials based nanoparticles for controlled hypoxia modulation and enhanced phototherapy","volume":"29","author":"Zhang","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41580-022-00456-z","article-title":"Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology","volume":"23","author":"Sies","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0040","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nature09973","article-title":"TLR signalling augments macrophage bactericidal activity through mitochondrial ROS","volume":"472","author":"West","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ceb.2014.09.010","article-title":"ROS-dependent signal transduction","volume":"33","author":"Reczek","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0050","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1089\/ars.2015.6247","article-title":"The redox code","volume":"23","author":"Jones","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0055","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/cr.2013.88","article-title":"ROS sets the stage for macrophage differentiation","volume":"23","author":"Covarrubias","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0060","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cellsig.2015.03.013","article-title":"Reactive oxygen species in the tumor niche triggers altered activation of macrophages and immunosuppression: role of fluoxetine","volume":"27","author":"Ghosh","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0065","doi-asserted-by":"crossref","first-page":"17686","DOI":"10.1073\/pnas.1012016107","article-title":"Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species","volume":"107","author":"Kraaij","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110978","article-title":"Reactive oxygen species in immune cells: a new antitumor target","volume":"133","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.784612","article-title":"Reactive oxygen species in anticancer immunity: a double-edged sword","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Bioeng. Biotech."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-019-0269-6","article-title":"Enhancing cancer immunotherapy with nanomedicine","volume":"20","author":"Irvine","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrclinonc.2016.211","article-title":"Radiotherapy and immunotherapy: a beneficial liaison?","volume":"14","author":"Weichselbaum","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0090","doi-asserted-by":"crossref","first-page":"10147","DOI":"10.1021\/acsnano.7b04736","article-title":"Inhibiting metastasis and preventing tumor relapse by triggering host immunity with tumor-targeted photodynamic therapy using photosensitizer-loaded functional nanographenes","volume":"11","author":"Yu","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002104","article-title":"Immune checkpoint inhibitor-based strategies for synergistic cancer therapy","volume":"10","author":"He","year":"2021","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0105","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","article-title":"Turning cold tumors hot: from molecular mechanisms to clinical applications","volume":"43","author":"Zhang","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2013.09.018","article-title":"Abscopal effects of radiation therapy: a clinical review for the radiobiologist","volume":"356","author":"Siva","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0120","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1021\/acs.nanolett.6b01994","article-title":"Acid-activatable versatile micelleplexes for PD-L1 blockade-enhanced cancer photodynamic immunotherapy","volume":"16","author":"Wang","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0125","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41568-019-0186-9","article-title":"Improving cancer immunotherapy through nanotechnology","volume":"19","author":"Goldberg","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0130","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41578-019-0108-1","article-title":"Cancer nanomedicine for combination cancer immunotherapy","volume":"4","author":"Nam","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0140","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrclinonc.2015.120","article-title":"Opportunities and challenges of radiotherapy for treating cancer","volume":"12","author":"Schaue","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/cancers8030028","article-title":"Paradigm shift in radiation biology\/radiation oncology\u2014exploitation of the \u201cH2O2 effect\u201d for radiotherapy using low-LET (linear energy transfer) radiation such as X-rays and high-energy electrons","volume":"8","author":"Ogawa","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0150","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/s41467-018-04703-w","article-title":"Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy","volume":"9","author":"Ni","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41571-018-0046-7","article-title":"Safety of combining radiotherapy with immune-checkpoint inhibition","volume":"15","author":"Hwang","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0160","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/CCO.0000000000000628","article-title":"Combining immunotherapy and radiotherapy in head and neck squamous cell cancers: which perspectives?","volume":"32","author":"Biau","year":"2020","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trecan.2021.10.003","article-title":"Radiotherapy and immunotherapy: open questions and future strategies","volume":"8","author":"Pointer","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41467-020-20243-8","article-title":"Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0175","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nnano.2017.113","article-title":"Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy","volume":"12","author":"Min","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0180","doi-asserted-by":"crossref","first-page":"8450","DOI":"10.1021\/acsnano.0c10764","article-title":"Zoledronic acid\u2013gadolinium coordination polymer nanorods for improved tumor radioimmunotherapy by synergetically inducing immunogenic cell death and reprogramming the immunosuppressive microenvironment","volume":"15","author":"Huang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0185","first-page":"1","article-title":"Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy","volume":"16","author":"Zheng","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0190","doi-asserted-by":"crossref","first-page":"2103689","DOI":"10.1002\/advs.202103689","article-title":"Immunotherapy of malignant glioma by noninvasive administration of TLR9 agonist CpG nano-immunoadjuvant","volume":"9","author":"Wei","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0195","doi-asserted-by":"crossref","first-page":"1802228","DOI":"10.1002\/adma.201802228","article-title":"Nanoparticle-enhanced radiotherapy to trigger robust cancer immunotherapy","volume":"31","author":"Chen","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0200","doi-asserted-by":"crossref","first-page":"1700996","DOI":"10.1002\/adma.201700996","article-title":"Emerging nanotechnology and advanced materials for cancer radiation therapy","volume":"29","author":"Song","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0205","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1158\/1078-0432.CCR-16-1297","article-title":"First-in-human study testing a new radioenhancer using nanoparticles (NBTXR3) activated by radiation therapy in patients with locally advanced soft tissue sarcomas","volume":"23","author":"Bonvalot","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0210","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer \u2014 clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0220","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.abb4255","article-title":"Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic","volume":"369","author":"Chin Emily","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101405","article-title":"Manganese-phenolic nanoadjuvant combines sonodynamic therapy with cGAS-STING activation for enhanced cancer immunotherapy","volume":"43","author":"Tian","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0230","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0235","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41571-021-00539-4","article-title":"Therapeutic targeting of the hypoxic tumour microenvironment","volume":"18","author":"Singleton","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0240","doi-asserted-by":"crossref","first-page":"11522","DOI":"10.1002\/anie.201805138","article-title":"Innovative strategies for hypoxic-tumor photodynamic therapy","volume":"57","author":"Li","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0245","doi-asserted-by":"crossref","first-page":"2006742","DOI":"10.1002\/smll.202006742","article-title":"Type I photosensitizers revitalizing photodynamic oncotherapy","volume":"17","author":"Chen","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/viw2.6","article-title":"Application of nanotechnology for enhancing photodynamic therapy via ameliorating, neglecting, or exploiting tumor hypoxia","volume":"1","author":"Hu","year":"2020","journal-title":"VIEW"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0255","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1039\/D0SC00785D","article-title":"Type I photosensitizers based on phosphindole oxide for photodynamic therapy: apoptosis and autophagy induced by endoplasmic reticulum stress","volume":"11","author":"Zhuang","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0260","doi-asserted-by":"crossref","first-page":"1900132","DOI":"10.1002\/adhm.201900132","article-title":"Photosensitizers for photodynamic therapy","volume":"8","author":"Lan","year":"2019","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0265","doi-asserted-by":"crossref","first-page":"9132","DOI":"10.7150\/thno.46076","article-title":"Tumor microenvironment-triggered nanosystems as dual-relief tumor hypoxia immunomodulators for enhanced phototherapy","volume":"10","author":"Shen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2019.122079","article-title":"Tumor hypoxia relief overcomes multidrug resistance and immune inhibition for self-enhanced photodynamic therapy","volume":"375","author":"He","year":"2019","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101084","article-title":"ROS and the DNA damage response in cancer","volume":"25","author":"Srinivas","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0280","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0285","doi-asserted-by":"crossref","first-page":"1900996","DOI":"10.1002\/adhm.201900996","article-title":"Photodynamic therapy combined with antihypoxic signaling and CpG adjuvant as an in situ tumor vaccine based on metal\u2013organic framework nanoparticles to boost cancer immunotherapy","volume":"9","author":"Cai","year":"2020","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0290","doi-asserted-by":"crossref","first-page":"1802479","DOI":"10.1002\/adma.201802479","article-title":"Large-pore mesoporous-silica-coated upconversion nanoparticles as multifunctional immunoadjuvants with ultrahigh photosensitizer and antigen loading efficiency for improved cancer photodynamic immunotherapy","volume":"30","author":"Ding","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0295","doi-asserted-by":"crossref","first-page":"eaba4024","DOI":"10.1126\/sciadv.aba4024","article-title":"Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed","volume":"6","author":"Fang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0300","doi-asserted-by":"crossref","first-page":"2105631","DOI":"10.1002\/advs.202105631","article-title":"Remodeling tumor-associated neutrophils to enhance dendritic cell-based HCC neoantigen nano-vaccine efficiency","volume":"9","author":"Wang","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121411","article-title":"Photosensitizer-induced HPV16 E7 nanovaccines for cervical cancer immunotherapy","volume":"282","author":"Zhang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0310","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1021\/jacs.8b01072","article-title":"Nanoscale metal-organic framework overcomes hypoxia for photodynamic therapy primed cancer immunotherapy","volume":"140","author":"Lan","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0315","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1021\/acs.nanolett.8b00040","article-title":"Smart nanoreactors for pH-responsive tumor homing, mitochondria-targeting, and enhanced photodynamic-immunotherapy of cancer","volume":"18","author":"Yang","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0320","doi-asserted-by":"crossref","first-page":"eaau6584","DOI":"10.1126\/sciimmunol.aau6584","article-title":"Engineering nanoparticles to locally activate T cells in the tumor microenvironment","volume":"4","author":"Wang","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0325","doi-asserted-by":"crossref","first-page":"12845","DOI":"10.1021\/acsami.0c20422","article-title":"Dual-sensitive PEG-sheddable nanodrug hierarchically incorporating PD-L1 antibody and zinc phthalocyanine for improved immuno-photodynamic therapy","volume":"13","author":"Su","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0330","doi-asserted-by":"crossref","first-page":"1707249","DOI":"10.1002\/adfm.201707249","article-title":"Size\/charge changeable acidity-responsive micelleplex for photodynamic-improved PD-L1 immunotherapy with enhanced tumor penetration","volume":"28","author":"Dai","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0335","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1021\/acsnano.9b07212","article-title":"Smart nanovesicle-mediated immunogenic cell death through tumor microenvironment modulation for effective photodynamic immunotherapy","volume":"14","author":"Yang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0340","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/acsnano.7b09112","article-title":"Enhanced immunotherapy based on photodynamic therapy for both primary and lung metastasis tumor eradication","volume":"12","author":"Song","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0345","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1021\/acs.nanolett.9b04012","article-title":"Sheddable prodrug vesicles combating adaptive immune resistance for improved photodynamic immunotherapy of cancer","volume":"20","author":"Gao","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0350","doi-asserted-by":"crossref","first-page":"2007149","DOI":"10.1002\/adfm.202007149","article-title":"Metformin mediated PD-L1 downregulation in combination with photodynamic-immunotherapy for treatment of breast cancer","volume":"31","author":"Hu","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0355","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1021\/acsnano.7b00715","article-title":"Near-infrared-triggered photodynamic therapy with multitasking upconversion nanoparticles in combination with checkpoint blockade for immunotherapy of colorectal cancer","volume":"11","author":"Xu","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201900927","article-title":"Light-triggered in situ gelation to enable robust photodynamic-immunotherapy by repeated stimulations","volume":"31","author":"Meng","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0365","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.7150\/thno.26758","article-title":"Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy","volume":"8","author":"Ou","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120582","article-title":"Corn-like Au\/Ag nanorod-mediated NIR-II photothermal\/photodynamic therapy potentiates immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment","volume":"268","author":"Jin","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0375","doi-asserted-by":"crossref","first-page":"12680","DOI":"10.1002\/anie.201906288","article-title":"Organic semiconducting pro-nanostimulants for near-infrared photoactivatable cancer immunotherapy","volume":"58","author":"Li","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0380","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41467-017-01050-0","article-title":"Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses","volume":"8","author":"Yang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.126481","article-title":"Oxidation-sensitive polymeric nanocarrier-mediated cascade PDT chemotherapy for synergistic cancer therapy and potentiated checkpoint blockade immunotherapy","volume":"404","author":"Wu","year":"2021","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0390","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn5062029","article-title":"Nanoparticle-based immunotherapy for cancer","volume":"9","author":"Shao","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0395","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1021\/acsnano.8b08346","article-title":"In situ dendritic cell vaccine for effective cancer immunotherapy","volume":"13","author":"Yang","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0400","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jconrel.2022.05.005","article-title":"Roadmap to next-generation cancer vaccines","volume":"347","author":"Zheng","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0405","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0410","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0415","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1038\/s41467-021-25416-7","article-title":"PD-L1 degradation is regulated by electrostatic membrane association of its cytoplasmic domain","volume":"12","author":"Wen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0420","doi-asserted-by":"crossref","first-page":"1800229","DOI":"10.1002\/advs.201800229","article-title":"Enhanced melanoma-targeted therapy by \"fru-blocked\" phenyboronic acid-modified multiphase antimetastatic micellar nanoparticles","volume":"5","author":"Long","year":"2018","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0425","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.apsb.2020.07.013","article-title":"The progress and perspective of nanoparticle-enabled tumor metastasis treatment","volume":"10","author":"Zhang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0430","doi-asserted-by":"crossref","first-page":"18252","DOI":"10.1039\/C8RA02563K","article-title":"Preparation and characterization of Ag\u2013Pd bimetallic nano-catalysts in thermosensitive microgel nano-reactor","volume":"8","author":"Zhang","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0435","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11095-017-2298-9","article-title":"Synthesis and characterisation of photocrosslinked poly(ethylene glycol) diacrylate implants for sustained ocular drug delivery","volume":"35","author":"McAvoy","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0440","doi-asserted-by":"crossref","first-page":"1900004","DOI":"10.1002\/adfm.201900004","article-title":"Tumor microenvironment responsive drug-dye-peptide nanoassembly for enhanced tumor-targeting, penetration, and photo-chemo-immunotherapy","volume":"29","author":"Peng","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0445","doi-asserted-by":"crossref","first-page":"1902960","DOI":"10.1002\/adma.201902960","article-title":"Self-amplified drug delivery with light-inducible nanocargoes to enhance cancer immunotherapy","volume":"31","author":"Feng","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0450","doi-asserted-by":"crossref","first-page":"e2102043","DOI":"10.1002\/advs.202102043","article-title":"Overcoming chemoimmunotherapy-induced immunosuppression by assemblable and depot forming immune modulating nanosuspension","volume":"8","author":"Jin","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0455","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1038\/s41467-021-24902-2","article-title":"Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles","volume":"12","author":"Qi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0460","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1039\/C8CS00618K","article-title":"Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer","volume":"48","author":"Liu","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0465","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nri3843","article-title":"Fever and the thermal regulation of immunity: the immune system feels the heat","volume":"15","author":"Evans","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0470","doi-asserted-by":"crossref","first-page":"11967","DOI":"10.1021\/acsnano.9b06040","article-title":"Near-infrared II phototherapy induces deep tissue immunogenic cell death and potentiates cancer immunotherapy","volume":"13","author":"Ma","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0475","doi-asserted-by":"crossref","first-page":"1801389","DOI":"10.1002\/adfm.201801389","article-title":"Myeloid-derived suppressor cell membrane-coated magnetic nanoparticles for cancer theranostics by inducing macrophage polarization and synergizing immunogenic cell death","volume":"28","author":"Yu","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0480","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41467-018-03473-9","article-title":"Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer","volume":"9","author":"Nam","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0485","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1039\/C9CS00648F","article-title":"Multifunctional sonosensitizers in sonodynamic cancer therapy","volume":"49","author":"Son","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0490","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/02656736.2014.992484","article-title":"Treating cancer with sonodynamic therapy: a review","volume":"31","author":"Costley","year":"2015","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0495","doi-asserted-by":"crossref","first-page":"1800180","DOI":"10.1002\/adma.201800180","article-title":"Metal\u2013organic-framework-derived carbon nanostructure augmented sonodynamic cancer therapy","volume":"30","author":"Pan","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0500","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1007\/s12274-020-2992-5","article-title":"Recent advances in nanomaterials for sonodynamic therapy","volume":"13","author":"Xu","year":"2020","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0505","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cej.2018.01.060","article-title":"Nanoparticle-assisted ultrasound: a special focus on sonodynamic therapy against cancer","volume":"340","author":"Canavese","year":"2018","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0510","doi-asserted-by":"crossref","first-page":"1805764","DOI":"10.1002\/adfm.201805764","article-title":"Functionalized holmium-doped hollow silica nanospheres for combined sonodynamic and hypoxia-activated therapy","volume":"29","author":"Wang","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0515","doi-asserted-by":"crossref","first-page":"1901335","DOI":"10.1002\/adhm.201901335","article-title":"Biomimetic decoy inhibits tumor growth and lung metastasis by reversing the drawbacks of sonodynamic therapy","volume":"9","author":"Zhao","year":"2020","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0520","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2018.10.007","article-title":"Crosslinked self-assembled nanoparticles for chemo-sonodynamic combination therapy favoring antitumor, antimetastasis management and immune responses","volume":"290","author":"Liu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0525","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12951-021-01094-x","article-title":"Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer","volume":"19","author":"Wan","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121250","article-title":"Perfluorocarbon loaded fluorinated covalent organic polymers with effective sonosensitization and tumor hypoxia relief enable synergistic sonodynamic-immunotherapy","volume":"280","author":"Yang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0535","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7150\/thno.64862","article-title":"A hydrogen peroxide economizer for on-demand oxygen production-assisted robust sonodynamic immunotherapy","volume":"12","author":"Jiang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0540","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1080\/10717544.2022.2044937","article-title":"Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Delivery"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0545","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2147\/IJN.S290796","article-title":"Nanosonosensitizer-augmented sonodynamic therapy combined with checkpoint blockade for cancer immunotherapy","volume":"16","author":"Lin","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0550","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12951-022-01287-y","article-title":"Biomimetic nanoprobe-augmented triple therapy with photothermal, sonodynamic and checkpoint blockade inhibits tumor growth and metastasis","volume":"20","author":"Lin","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0555","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.1021\/acsnano.0c03833","article-title":"Ultrasound-driven biomimetic nanosystem suppresses tumor growth and metastasis through sonodynamic therapy, CO therapy, and indoleamine 2,3-dioxygenase inhibition","volume":"14","author":"Zhang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121466","article-title":"Chemiluminescence resonance energy transfer-based immunostimulatory nanoparticles for sonoimmunotherapy","volume":"283","author":"Jeon","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0565","first-page":"152244","article-title":"Necroptosis-elicited host immunity: GOx-loaded MoS2 nanocatalysts for self-amplified chemodynamic immunotherapy","volume":"15","author":"Xie","year":"2021","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0570","doi-asserted-by":"crossref","first-page":"2100130","DOI":"10.1002\/adtp.202100130","article-title":"Polymersome nanoreactor-mediated combination chemodynamic-immunotherapy via ROS production and enhanced STING activation","volume":"4","author":"Zhou","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119761","article-title":"ROS-augmented and tumor-microenvironment responsive biodegradable nanoplatform for enhancing chemo-sonodynamic therapy","volume":"234","author":"An","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0580","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.1039\/C6CS00616G","article-title":"Overcoming the Achilles' heel of photodynamic therapy","volume":"45","author":"Fan","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0585","article-title":"Chemiluminescent nanomicelles for imaging hydrogen peroxide and self-therapy in photodynamic therapy","volume":"2011","author":"Chen","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0590","doi-asserted-by":"crossref","first-page":"1901156","DOI":"10.1002\/smll.201901156","article-title":"Synergistic amplification of oxidative stress\u2013mediated antitumor activity via liposomal dichloroacetic acid and MOF-Fe2+","volume":"15","author":"Sun","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0595","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1021\/acsnano.1c01077","article-title":"Interfacially engineered ZnxMn1\u2013xS@polydopamine hollow nanospheres for glutathione depleting photothermally enhanced chemodynamic therapy","volume":"15","author":"Ruan","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0600","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/jacs.8b08714","article-title":"Self-assembled copper\u2013amino acid nanoparticles for in situ glutathione \u201cAND\u201d H2O2 sequentially triggered chemodynamic therapy","volume":"141","author":"Ma","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0605","doi-asserted-by":"crossref","first-page":"2104223","DOI":"10.1002\/adma.202104223","article-title":"Manipulating intratumoral fenton chemistry for enhanced chemodynamic and chemodynamic-synergized multimodal therapy","volume":"33","author":"Zhou","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100946","article-title":"Recent progress of chemodynamic therapy-induced combination cancer therapy","volume":"35","author":"Wang","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0615","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS\u2013STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0620","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.chempr.2019.05.013","article-title":"Nanoscale metal-organic framework mediates radical therapy to enhance cancer immunotherapy","volume":"5","author":"Ni","year":"2019","journal-title":"Chem"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0625","doi-asserted-by":"crossref","first-page":"43456","DOI":"10.1021\/acsami.0c12824","article-title":"Covalent organic framework-based nanocomposite for synergetic photo-, chemodynamic-, and immunotherapies","volume":"12","author":"Liu","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0630","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1021\/acs.bioconjchem.0c00209","article-title":"Copper-doped nanoscale covalent organic polymer for augmented photo\/chemodynamic synergistic therapy and immunotherapy","volume":"31","author":"Hu","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0635","doi-asserted-by":"crossref","first-page":"2006231","DOI":"10.1002\/smll.202006231","article-title":"Copper-based nanoscale coordination polymers augmented tumor radioimmunotherapy for immunogenic cell death induction and T-cell infiltration","volume":"17","author":"Wang","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0640","doi-asserted-by":"crossref","first-page":"11953","DOI":"10.1021\/acsnano.1c03128","article-title":"Catalytically active CoFe2O4 nanoflowers for augmented sonodynamic and chemodynamic combination therapy with elicitation of robust immune response","volume":"15","author":"Fu","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0645","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1021\/acsnano.1c08619","article-title":"Nanotransferrin-based programmable catalysis mediates three-pronged induction of oxidative stress to enhance cancer immunotherapy","volume":"16","author":"Bai","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0650","doi-asserted-by":"crossref","first-page":"20210157","DOI":"10.1002\/EXP.20210157","article-title":"Recent applications of immunomodulatory biomaterials for disease immunotherapy","volume":"2","author":"Dai","year":"2022","journal-title":"Exploration"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0655","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jconrel.2020.10.030","article-title":"Serum protein-based nanoparticles for cancer diagnosis and treatment","volume":"329","author":"Iqbal","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0660","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0665","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1039\/C6CS00271D","article-title":"Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy","volume":"45","author":"Zhou","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0670","doi-asserted-by":"crossref","first-page":"13012","DOI":"10.1039\/C6DT01428C","article-title":"Upconverting nanoparticles for the near infrared photoactivation of transition metal complexes: new opportunities and challenges in medicinal inorganic photochemistry","volume":"45","author":"Ruggiero","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0675","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3390\/cancers13143484","article-title":"Light technology for efficient and effective photodynamic therapy: a critical review","volume":"13","author":"Algorri","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0680","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1002\/smll.201501923","article-title":"Nanocomposite-based photodynamic therapy strategies for deep tumor treatment","volume":"11","author":"Hu","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0685","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nnano.2009.326","article-title":"Second window for in vivo imaging","volume":"4","author":"Smith","year":"2009","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0690","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1088\/0022-3727\/38\/15\/004","article-title":"Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000nm","volume":"38","author":"Bashkatov","year":"2005","journal-title":"J. Phys. D. Appl. Phys."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0695","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/php.13219","article-title":"Light sources and dosimetry techniques for photodynamic therapy","volume":"96","author":"Kim","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0700","article-title":"System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer","volume":"15","author":"Johannes","year":"2010","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0705","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1039\/C4CS00392F","article-title":"An overview of nanoparticles commonly used in fluorescent bioimaging","volume":"44","author":"Wolfbeis","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0710","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/cr400478f","article-title":"Upconversion luminescent materials: advances and applications","volume":"115","author":"Zhou","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0715","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nbt1188","article-title":"Self-illuminating quantum dot conjugates for in vivo imaging","volume":"24","author":"So","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0720","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1039\/D0NH00672F","article-title":"Near-infrared small molecule coupled with rigidness and flexibility for high-performance multimodal imaging-guided photodynamic and photothermal synergistic therapy","volume":"6","author":"Li","year":"2021","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0725","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1021\/acsnano.6b01401","article-title":"Scintillating nanoparticles as energy mediators for enhanced photodynamic therapy","volume":"10","author":"Kamkaew","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0730","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000083981","article-title":"Effect of heavy metals on, and handling by, the kidney","volume":"99","author":"Barbier","year":"2005","journal-title":"Nephron Physiol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0735","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1039\/C9SC00729F","article-title":"PEGylated rhenium nanoclusters: a degradable metal photothermal nanoagent for cancer therapy","volume":"10","author":"Miao","year":"2019","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103180","article-title":"Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectives","volume":"157","author":"Mortezaee","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0745","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2011.09.049","article-title":"Maximizing tumor immunity with fractionated radiation","volume":"83","author":"Schaue","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0750","doi-asserted-by":"crossref","first-page":"1483406","DOI":"10.1155\/2019\/1483406","article-title":"Combination with stereotactic body radiotherapy offers a promising strategy to overcome resistance to immunotherapy in advanced renal cell cancer","volume":"2019","author":"Sun","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0755","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti\u2013CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0760","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1088\/0031-9155\/61\/7\/R57","article-title":"Revisiting photodynamic therapy dosimetry: reductionist & surrogate approaches to facilitate clinical success","volume":"61","author":"Pogue","year":"2016","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0765","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0770","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","article-title":"Progress in tumor-associated macrophage (TAM)-targeted therapeutics","volume":"114","author":"Ngambenjawong","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0775","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0780","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0785","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","article-title":"Diverging inflammasome signals in tumorigenesis and potential targeting","volume":"19","author":"Karki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0790","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","article-title":"Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways","volume":"19","author":"Kraehenbuehl","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0795","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0800","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.02.040_bb0805","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1136\/gutjnl-2016-313498","article-title":"Gut microbiota modulate T cell trafficking into human colorectal cancer","volume":"67","author":"Cremonesi","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2023.02.040_bb0810","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature15520","article-title":"Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy","volume":"527","author":"Peng","year":"2015","journal-title":"Nature"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923001529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923001529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:42:39Z","timestamp":1759164159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923001529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":162,"alternative-id":["S0168365923001529"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.02.040","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reactive oxygen species-powered cancer immunotherapy: Current status and challenges","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.02.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}